LexDanaLexDanabeta
Inventor

Heinrich Rueeger

Inventor
Flueh, CH

Overview

20→
Patents
2011–2020
Patent span
Human necessities
Primary field (CPC A)

Patents· 20 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds31%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
A61KPreparations for medical, dental or toiletry purposes26%
C07BGeneral methods of organic chemistry9%
C07CAcyclic or carbocyclic compounds3%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium2%
PatentTitleYear
10,683,287Heterocyclic derivatives and their use in the treatment of neurological disorders202010,301,296Heterocyclic derivatives and their use in the treatment of neurological disorders201910,202,371Oxazolidin-2-one-pyrimidine derivatives and the use thereof as phosphatidylinositol-3-kinase inhibitors201910,035,794Heterocyclic derivatives and their use in the treatment of neurological disorders20189,890,166'Imidazopyrrolidine derivatives and their use in the treatment of disease'20189,714,249'Pyrazolo-pyrrolidin-4-one derivatives and their use in the treatment of disease'20179,624,247'Pyrazolo-pyrrolidin-4-one derivatives as bet inhibitors and their use in the treatment of disease'20179,550,758'Heterocyclic derivatives and their use in the treatment of neurological disorders'20179,458,177'Oxazolidin-2-one compounds and uses thereof'20169,296,733'Oxazolidin-2-one-pyrimidine derivative and use thereof for the treatment of conditions, diseases and disorders dependent upon PI3 kinases'20169,284,284'Oxazine derivatives and their use in the treatment of disease'20169,163,011'Oxazine derivatives and their use in the treatment of disease'20158,975,417'Pyrazolopyrrolidine derivatives and their use in the treatment of disease'20158,865,712'Heterocyclic derivatives and their use in the treatment of neurological disorders'20148,865,894'Oxazolidin-2-one compounds and uses thereof'20148,637,508'Heterocyclic derivatives and their use in the treatment of neurological disorders'20148,338,413'Oxazine derivatives and their use in the treatment of neurological disorders'20128,143,416'Alternative synthesis of renin inhibitors and intermediates thereof'20128,093,406'Cyclic sulfones with aminobenzyl substitution useful as BACE inhibitors'20127,910,774'Alternative synthesis of renin inhibitors and intermediates thereof'2011

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2011–2020Patents assigned to NOVARTIS AG (20)· patent assignee history
2011–2020Based in Flueh, CH· patent location history
2012–2018Patents assigned to RUEEGER HEINRICH (14)· patent assignee history
2012–2017Patents assigned to MACHAUER RAINER (6)· patent assignee history
2012–2017Patents assigned to VEENSTRA SIEM JACOB (6)· patent assignee history
2012–2017Patents assigned to LUEOEND RAINER MARTIN (5)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
NOVARTIS AG202011–2020
RUEEGER HEINRICHself142012–2018
MACHAUER RAINER62012–2017
VEENSTRA SIEM JACOB62012–2017
LUEOEND RAINER MARTIN52012–2017
Locations
LocationPatentsSpan
Flueh, CH202011–2020